Colgate Announces 3rd Quarter 2017 Results
Net income and Diluted earnings per share in third quarter 2017 were
Net income and Diluted earnings per share in third quarter 2016 were
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods and the gain on sale of land in
Gross profit margin was 60.0% in third quarter 2017 versus 60.1% in third quarter 2016. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin was 60.4% in third quarter 2017, even with the year ago quarter. Cost savings from the Company's funding-the-growth initiatives were offset by higher raw and packaging material costs.
Selling, general and administrative expenses were 36.0% of Net sales in
third quarter 2017 versus 34.2% of Net sales in third quarter 2016.
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods, Selling, general and administrative expenses
increased by 140 basis points to 35.4% of Net sales in third quarter
2017 as a result of increased advertising investment. Worldwide
advertising investment increased 19% to
Operating profit decreased to
Net cash provided by operations year to date decreased to
"Advertising investment increased both absolutely and as a percent to sales versus third quarter 2016 across every operating division. This increased level of spending should continue over the balance of the year in support of new products, our base businesses and longer-term consumption-building activities.
"Colgate's leadership of the global toothpaste market continued during the quarter with our global market share now at 43.5% year to date. Our global leadership in manual toothbrushes also continued with Colgate's global market share in that category now at 32.6% year to date."
Building on the Company's successful implementation of the Global Growth
and Efficiency Program to date, on
"On a GAAP basis, based on current spot rates and including the impact of the expanded Global Growth and Efficiency Program, we continue to plan for a year of gross margin expansion and still expect a mid-single-digit earnings per share percentage decline.
"Excluding charges resulting from the Global Growth and Efficiency Program and the other 2016 one-time items previously disclosed, based on current spot rates, we continue to plan for a year of strong operating cash flow, gross margin expansion, increased advertising investment and low-single-digit earnings per share growth."
At
The following are comments about divisional performance for third quarter 2017 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information tables for additional information on divisional net sales and operating profit.
North
America Net sales decreased 0.5% in third quarter 2017. Unit volume
increased 3.0% with 4.0% lower pricing, while foreign exchange was
positive 0.5%. Organic sales for
Operating profit in
In the
New products succeeding in other categories include
Latin
America Net sales increased 6.5% in third quarter 2017. Unit volume
increased 3.0% with 2.5% higher pricing and foreign exchange was
positive 1.0%. Volume gains were led by
Operating profit in
Colgate maintained its leadership in toothpaste in
New products contributing to growth in other categories include Colgate Total 12 and Colgate Plax Ice Glacial mouthwashes, Protex Pro-Hidrata shower gel and bar soap, Palmolive Natural Secrets shower gel and bar soap, Lady Speed Stick Derma + Omega 3 antiperspirant, Suavitel Sweet Pleasures fabric conditioner, Axion Fusion Clean dish liquid and Fabuloso Complete liquid cleaner.
Operating profit in
Colgate maintained its oral care leadership in
Premium innovations succeeding in other product categories include
Asia
Pacific Net sales increased 0.5% during third quarter 2017. Unit volume
and pricing were even with the year ago quarter and foreign exchange was
positive 0.5%. Volume gains in the
Operating profit in
Colgate continued its toothpaste leadership in the
New products succeeding in other categories in the region include
Colgate Slim Soft Advanced, Colgate Slim Soft Micro Silky,
Operating profit in
Colgate continued its toothpaste leadership in
Hill's Pet Nutrition (15% of Company Sales)
Hill's
Net sales increased 2.0% during third quarter 2017. Unit volume
increased 1.0%, pricing was even with the year ago quarter and foreign
exchange was positive 1.0%. Volume gains in
Hill's Operating profit decreased 1% in third quarter 2017 to
Successful products contributing to sales in the
Successful products contributing to sales internationally include Hill's Prescription Diet i/d, Hill's Prescription Diet k/d and k/d + Mobility, Hill's Prescription Diet Derm Defense, Hill's Science Diet Small & Mini and Hill's Science Diet Youthful Vitality.
***
About
Market Share Information
Management
uses market share information as a key indicator to monitor business
health and performance. References to market share in this press release
are based on a combination of consumption and market share data provided
by third-party vendors, primarily Nielsen, and internal estimates. All
market share references represent the percentage of the dollar value of
sales of our products, relative to all product sales in the category in
the countries in which the Company competes and purchases data
(excluding
Cautionary Statement on Forward-Looking Statements
This
press release and the related webcast may contain forward-looking
statements (as that term is defined in the
Non-GAAP Financial Measures
The
following provides information regarding the non-GAAP financial measures
used in this earnings release and/or the related webcast:
This release discusses Net sales growth (GAAP) and organic sales growth,
which is Net sales growth excluding the impact of foreign exchange,
acquisitions and divestments (non-GAAP). Management believes the organic
sales growth measure provides investors and analysts with useful
supplemental information regarding the Company's underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
"Geographic Sales Analysis Percentage Changes" for the three and nine
months ended
To supplement Colgate's Condensed Consolidated Statements of Income
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Effective income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is a non-GAAP measure
and may not be comparable to similarly titled measures reported by other
companies. See "Condensed Consolidated Statements of Cash Flows" for the
nine months ended
(See attached tables for third quarter results.)
Table 1 | |||||||||
|
|||||||||
Condensed Consolidated Statements of Income | |||||||||
For the Three Months Ended |
|||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||
2017 | 2016 | ||||||||
Net sales | $ | 3,974 | $ | 3,867 | |||||
Cost of sales | 1,591 | 1,543 | |||||||
Gross profit | 2,383 | 2,324 | |||||||
Gross profit margin | 60.0 | % | 60.1 | % | |||||
Selling, general and administrative expenses | 1,429 | 1,322 | |||||||
Other (income) expense, net | 27 | (69 | ) | ||||||
Operating profit | 927 | 1,071 | |||||||
Operating profit margin | 23.3 | % | 27.7 | % | |||||
Interest (income) expense, net | 27 | 25 | |||||||
Income before income taxes | 900 | 1,046 | |||||||
Provision for income taxes | 250 | 300 | |||||||
Effective tax rate | 27.8 | % | 28.7 | % | |||||
Net income including noncontrolling interests | 650 | 746 | |||||||
Less: Net income attributable to noncontrolling interests | 43 | 44 | |||||||
Net income attributable to |
$ | 607 | $ | 702 | |||||
Earnings per common share | |||||||||
Basic | $ | 0.69 | $ | 0.79 | |||||
Diluted | $ | 0.68 | $ | 0.78 | |||||
Average common shares outstanding | |||||||||
Basic | 880.7 | 891.9 | |||||||
Diluted | 886.3 | 899.2 | |||||||
Table 2 | |||||||||
|
|||||||||
Condensed Consolidated Statements of Income | |||||||||
For the Nine Months Ended |
|||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||
2017 | 2016 | ||||||||
Net sales | $ | 11,562 | $ | 11,474 | |||||
Cost of sales | 4,610 | 4,598 | |||||||
Gross profit | 6,952 | 6,876 | |||||||
Gross profit margin | 60.1 | % | 59.9 | % | |||||
Selling, general and administrative expenses | 4,124 | 3,996 | |||||||
Other (income) expense, net | 163 | (2 | ) | ||||||
Operating profit | 2,665 | 2,882 | |||||||
Operating profit margin | 23.0 | % | 25.1 | % | |||||
Interest (income) expense, net | 74 | 78 | |||||||
Income before income taxes | 2,591 | 2,804 | |||||||
Provision for income taxes | 770 | 846 | |||||||
Effective tax rate | 29.7 | % | 30.2 | % | |||||
Net income including noncontrolling interests | 1,821 | 1,958 | |||||||
Less: Net income attributable to noncontrolling interests | 120 | 123 | |||||||
Net income attributable to |
$ | 1,701 | $ | 1,835 | |||||
Earnings per common share | |||||||||
Basic(1) | $ | 1.93 | $ | 2.05 | |||||
Diluted(1) | $ | 1.91 | $ | 2.04 | |||||
Average common shares outstanding | |||||||||
Basic | 883.0 | 893.2 | |||||||
Diluted | 889.3 | 900.2 |
Note: |
(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for any year-to-date period. |
Table 3 | |||||||||||||
|
|||||||||||||
Condensed Consolidated Balance Sheets | |||||||||||||
As of |
|||||||||||||
(Dollars in Millions) (Unaudited) | |||||||||||||
|
|
|
|||||||||||
2017 | 2016 | 2016 | |||||||||||
Cash and cash equivalents | $ | 1,380 | $ | 1,315 | $ | 1,298 | |||||||
Receivables, net | 1,530 | 1,411 | 1,560 | ||||||||||
Inventories | 1,205 | 1,171 | 1,193 | ||||||||||
Other current assets | 621 | 441 | 713 | ||||||||||
Property, plant and equipment, net | 3,999 | 3,840 | 3,837 | ||||||||||
Other assets, including goodwill and intangibles | 4,040 | 3,945 | 4,022 | ||||||||||
Total assets | $ | 12,775 | $ | 12,123 | $ | 12,623 | |||||||
Total debt | $ | 6,527 | $ | 6,533 | $ | 6,523 | |||||||
Other current liabilities | 3,847 | 3,292 | 3,748 | ||||||||||
Other non-current liabilities | 2,134 | 2,281 | 2,124 | ||||||||||
Total liabilities | 12,508 | 12,106 | 12,395 | ||||||||||
|
(108 | ) | (243 | ) | (133 | ) | |||||||
Noncontrolling interests | 375 | 260 | 361 | ||||||||||
Total liabilities and equity | $ | 12,775 | $ | 12,123 | $ | 12,623 | |||||||
Supplemental Balance Sheet Information | |||||||||||||
Debt less cash, cash equivalents and marketable securities* | $ | 4,925 | $ | 5,147 | $ | 4,980 | |||||||
Working capital % of sales | (4.6 | )% | (2.2 | )% | (3.4 | )% |
*Marketable securities of |
Table 4 | |||||||||
|
|||||||||
Condensed Consolidated Statements of Cash Flows | |||||||||
For the Nine Months Ended |
|||||||||
(Dollars in Millions) (Unaudited) | |||||||||
2017 | 2016 | ||||||||
Operating Activities | |||||||||
Net income including noncontrolling interests | $ | 1,821 | $ | 1,958 | |||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | |||||||||
Depreciation and amortization | 354 | 329 | |||||||
Restructuring and termination benefits, net of cash | 80 | (1 | ) | ||||||
Stock-based compensation expense | 106 | 102 | |||||||
Gain on sale of land in |
— | (97 | ) | ||||||
Deferred income taxes | (2 | ) | 50 | ||||||
Voluntary benefit plan contributions | (81 | ) | (53 | ) | |||||
Cash effects of changes in: | |||||||||
Receivables | (50 | ) | (126 | ) | |||||
Inventories | 16 | 4 | |||||||
Accounts payable and other accruals | 39 | 101 | |||||||
Other non-current assets and liabilities | 12 | 50 | |||||||
Net cash provided by operations | 2,295 | 2,317 | |||||||
Investing Activities | |||||||||
Capital expenditures | (382 | ) | (392 | ) | |||||
Purchases of marketable securities and investments | (301 | ) | (271 | ) | |||||
Proceeds from sale of marketable securities and investments | 149 | 158 | |||||||
Proceeds from sale of land in |
— | 60 | |||||||
Other | 2 | — | |||||||
Net cash used in investing activities | (532 | ) | (445 | ) | |||||
Financing Activities | |||||||||
Principal payments on debt | (3,551 | ) | (5,446 | ) | |||||
Proceeds from issuance of debt | 3,478 | 5,447 | |||||||
Dividends paid | (1,070 | ) | (1,053 | ) | |||||
Purchases of treasury shares | (1,055 | ) | (913 | ) | |||||
Proceeds from exercise of stock options | 431 | 418 | |||||||
Net cash used in financing activities | (1,767 | ) | (1,547 | ) | |||||
Effect of exchange rate changes on Cash and cash equivalents | 69 | 3 | |||||||
Net increase (decrease) in Cash and cash equivalents | 65 | 328 | |||||||
Cash and cash equivalents at beginning of the period | 1,315 | 970 | |||||||
Cash and cash equivalents at end of the period | $ | 1,380 | $ | 1,298 | |||||
Supplemental Cash Flow Information | |||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | |||||||||
Net cash provided by operations | $ | 2,295 | $ | 2,317 | |||||
Less: Capital expenditures | (382 | ) | (392 | ) | |||||
Free cash flow before dividends | $ | 1,913 | $ | 1,925 | |||||
Income taxes paid | $ | 820 | $ | 696 | |||||
Table 5 | |||||||||||||||||
|
|||||||||||||||||
Segment Information | |||||||||||||||||
For the Three and Nine Months Ended |
|||||||||||||||||
(Dollars in Millions) (Unaudited) | |||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||||
|
|||||||||||||||||
Oral, Personal and Home Care | |||||||||||||||||
|
$ | 795 | $ | 800 | $ | 2,319 | $ | 2,393 | |||||||||
|
985 | 924 | 2,911 | 2,710 | |||||||||||||
|
642 | 609 | 1,784 | 1,803 | |||||||||||||
|
728 | 723 | 2,111 | 2,163 | |||||||||||||
|
251 | 250 | 738 | 720 | |||||||||||||
Total Oral, Personal and Home Care | 3,401 | 3,306 | 9,863 | 9,789 | |||||||||||||
Pet Nutrition | 573 | 561 | 1,699 | 1,685 | |||||||||||||
Total |
$ | 3,974 | $ | 3,867 | $ | 11,562 | $ | 11,474 | |||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||||
Operating Profit | |||||||||||||||||
Oral, Personal and Home Care | |||||||||||||||||
|
$ | 249 | $ | 273 | $ | 723 | $ | 762 | |||||||||
|
301 | 298 | 878 | 829 | |||||||||||||
|
162 | 158 | 447 | 437 | |||||||||||||
|
220 | 230 | 644 | 668 | |||||||||||||
|
44 | 50 | 134 | 138 | |||||||||||||
Total Oral, Personal and Home Care | 976 | 1,009 | 2,826 | 2,834 | |||||||||||||
Pet Nutrition | 161 | 162 | 481 | 479 | |||||||||||||
Corporate(1) | (210 | ) | (100 | ) | (642 | ) | (431 | ) | |||||||||
Total Operating Profit | $ | 927 | $ | 1,071 | $ | 2,665 | $ | 2,882 |
Note: |
(1) Corporate operations include costs related to stock options
and restricted stock units, research and development costs,
Corporate overhead costs, restructuring and related implementation
costs and gains and losses on sales of non-core product lines and
assets. |
Table 6 | ||||||||||||||||||||||
|
||||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | ||||||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
COMPONENTS OF SALES CHANGE | ||||||||||||||||||||||
Pricing | ||||||||||||||||||||||
Coupons | ||||||||||||||||||||||
Sales | Consumer & | |||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | ||||||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
|||||||||||||||
|
3.0 | % | 1.5 | % | 1.5 | % | 1.5 | % | 1.5 | % | — | % | 1.5 | % | ||||||||
|
5.5 | % | 1.0 | % | 3.0 | % | 3.0 | % | 3.0 | % |
(2.0 |
)% |
4.5 | % | ||||||||
|
6.5 | % | 5.5 | % | 3.0 | % | 3.0 | % | 3.0 | % | 2.5 | % | 1.0 | % | ||||||||
|
0.5 | % | — | % | — | % | — | % | — | % | — | % | 0.5 | % | ||||||||
|
0.5 | % |
(2.0 |
)% |
(4.5 |
)% |
(4.5 |
)% |
(4.5 |
)% |
2.5 | % | 2.5 | % | ||||||||
|
4.0 | % | 2.0 | % | 1.5 | % | 1.5 | % | 1.5 | % | 0.5 | % | 2.0 | % | ||||||||
|
(0.5 |
)% |
(1.0 |
)% |
3.0 | % | 3.0 | % | 3.0 | % |
(4.0 |
)% |
0.5 | % | ||||||||
Total CP Products | 3.0 | % | 1.5 | % | 1.5 | % | 1.5 | % | 1.5 | % | — | % | 1.5 | % | ||||||||
Hill's | 2.0 | % | 1.0 | % | 1.0 | % | 1.0 | % | 1.0 | % | — | % | 1.0 | % | ||||||||
Emerging Markets (1) | 4.5 | % | 3.0 | % | 1.0 | % | 1.0 | % | 1.0 | % | 2.0 | % | 1.5 | % | ||||||||
Developed Markets | 1.5 | % |
(0.5 |
)% |
2.0 | % | 2.0 | % | 2.0 | % |
(2.5 |
)% |
2.0 | % | ||||||||
Note: |
(1) Emerging Markets include |
Table 7 | |||||||||||||||||||||
|
|||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||
For the Nine Months Ended |
|||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||
Pricing | |||||||||||||||||||||
Coupons | |||||||||||||||||||||
Sales | Consumer & | ||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||||
|
1.0 | % | 0.5 | % |
(0.5 |
)% |
(0.5 |
)% |
(0.5 |
)% |
1.0 | % | 0.5 | % | |||||||
|
(1.0 |
)% |
— | % | 1.0 | % | 1.0 | % | 1.0 | % |
(1.0 |
)% |
(1.0 |
)% |
|||||||
|
7.5 | % | 6.5 | % | 2.0 | % | 2.0 | % | 2.0 | % | 4.5 | % | 1.0 | % | |||||||
|
(2.5 |
)% |
(1.5 |
)% |
(1.0 |
)% |
(1.0 |
)% |
(1.0 |
)% |
(0.5 |
)% |
(1.0 |
)% |
|||||||
|
2.5 | % |
(1.5 |
)% |
(6.0 |
)% |
(6.0 |
)% |
(6.0 |
)% |
4.5 | % | 4.0 | % | |||||||
|
2.0 | % | 2.0 | % | — | % | — | % | — | % | 2.0 | % | — | % | |||||||
|
(3.0 |
)% |
(3.0 |
)% |
(1.0 |
)% |
(1.0 |
)% |
(1.0 |
)% |
(2.0 |
)% |
— | % | |||||||
Total CP Products | 1.0 | % | 0.5 | % |
(0.5 |
)% |
(0.5 |
)% |
(0.5 |
)% |
1.0 | % | 0.5 | % | |||||||
Hill's | 1.0 | % | 0.5 | % |
(1.5 |
)% |
(1.5 |
)% |
(1.5 |
)% |
2.0 | % | 0.5 | % | |||||||
Emerging Markets (1) | 3.5 | % | 3.0 | % | — | % | — | % | — | % | 3.0 | % | 0.5 | % | |||||||
|
|||||||||||||||||||||
Developed Markets |
(2.0 |
)% |
(1.5 |
)% |
(1.0 |
)% |
(1.0 |
)% |
(1.0 |
)% |
(0.5 |
)% |
(0.5 |
)% |
Note: |
(1) Emerging Markets include |
Table 8 | ||||||||||||
|
||||||||||||
Non-GAAP Reconciliations | ||||||||||||
For the Three Months Ended |
||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||
Gross Profit | 2017 | 2016 | ||||||||||
Gross profit, GAAP | $ | 2,383 | $ | 2,324 | ||||||||
Global Growth and Efficiency Program | 16 | 11 | ||||||||||
Gross profit, non-GAAP | $ | 2,399 | $ | 2,335 | ||||||||
|
||||||||||||
Gross Profit Margin | 2017 | 2016 | Change | |||||||||
Gross profit margin, GAAP | 60.0 | % | 60.1 | % |
(10 |
) |
||||||
Global Growth and Efficiency Program | 0.4 | % | 0.3 | % | ||||||||
Gross profit margin, non-GAAP | 60.4 | % | 60.4 | % | — | |||||||
Selling, General and Administrative Expenses | 2017 | 2016 | ||||||||||
Selling, general and administrative expenses, GAAP | $ | 1,429 | $ | 1,322 | ||||||||
Global Growth and Efficiency Program |
(22 |
) |
(9 |
) |
||||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,407 | $ | 1,313 | ||||||||
|
||||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2017 | 2016 | Change | |||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 36.0 | % | 34.2 | % | 180 | |||||||
Global Growth and Efficiency Program |
(0.6 |
)% |
(0.2 |
)% |
||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.4 | % | 34.0 | % | 140 | |||||||
Other (Income) Expense, Net | 2017 | 2016 | ||||||||||
Other (income) expense, net, GAAP | $ | 27 | $ |
(69 |
) |
|||||||
Global Growth and Efficiency Program |
(20 |
) |
(22 |
) |
||||||||
Gain on sale of land in |
— | 97 | ||||||||||
Charge for a previously disclosed litigation matter | — |
(6 |
) |
|||||||||
Other (income) expense, net, non-GAAP | $ | 7 | $ | — | ||||||||
Operating Profit | 2017 | 2016 | % Change | |||||||||
Operating profit, GAAP | $ | 927 | $ | 1,071 |
(13 |
)% |
||||||
Global Growth and Efficiency Program | 58 | 42 | ||||||||||
Gain on sale of land in |
— |
(97 |
) |
|||||||||
Charge for a previously disclosed litigation matter | — | 6 | ||||||||||
Operating profit, non-GAAP | $ | 985 | $ | 1,022 |
(4 |
)% |
||||||
|
||||||||||||
Operating Profit Margin | 2017 | 2016 | Change | |||||||||
Operating profit margin, GAAP | 23.3 | % |
27.7 |
% |
(440 |
) |
||||||
Global Growth and Efficiency Program | 1.5 | % | 1.1 | % | ||||||||
Gain on sale of land in |
— | % |
(2.5) |
% |
||||||||
Charge for a previously disclosed litigation matter | — | % | 0.1 | % | ||||||||
Operating profit margin, non-GAAP | 24.8 | % | 26.4 | % |
(160 |
) |
||||||
Table 8 | ||||||||||||||||||||||||
Continued | ||||||||||||||||||||||||
|
||||||||||||||||||||||||
Non-GAAP Reconciliations | ||||||||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||||||||||||
2017 | ||||||||||||||||||||||||
Income Before
Income Taxes |
Provision For
Income Taxes(1) |
Net Income
Including Noncontrolling Interests |
Net Income
Attributable To Colgate- Palmolive Company |
Effective Income
Tax Rate(2) |
Diluted Earnings
Per Share(3) |
|||||||||||||||||||
As Reported GAAP | $ | 900 | $ | 250 | $ | 650 | $ | 607 | 27.8 | % | $ | 0.68 | ||||||||||||
Global Growth and Efficiency Program | 58 | 19 | 39 | 39 | 0.3 | % | 0.05 | |||||||||||||||||
Non-GAAP | $ | 958 | $ | 269 | $ | 689 | $ | 646 | 28.1 | % | $ | 0.73 | ||||||||||||
2016 | ||||||||||||||||||||||||
Income Before
Income Taxes |
Provision For Income Taxes(1) |
Net Income Including Noncontrolling Interests |
Net Income
Attributable To Colgate- Palmolive Company |
Effective Income
Tax Rate(2) |
Diluted Earnings
Per Share(3) |
|||||||||||||||||||
As Reported GAAP | $ | 1,046 | $ | 300 | $ | 746 | $ | 702 | 28.7 | % | $ | 0.78 | ||||||||||||
Global Growth and Efficiency Program | 42 | 10 | 32 | 32 | (0.2 | )% | 0.04 | |||||||||||||||||
Gain on sale of land in |
(97 | ) | (34 | ) | (63 | ) | (63 | ) | (0.6 | )% | (0.07 | ) | ||||||||||||
Benefits from previously disclosed tax matters | — | 22 | (22 | ) | (22 | ) | 2.2 | % | (0.02 | ) | ||||||||||||||
Charge for a previously disclosed litigation matter | 6 | 2 | 4 | 4 | — | % | — | |||||||||||||||||
Non-GAAP | $ | 997 | $ | 300 | $ | 697 | $ | 653 | 30.1 | % | $ | 0.73 |
Notes: |
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between GAAP and non-GAAP as a result of rounding. |
Table 9 | ||||||||||||
|
||||||||||||
Non-GAAP Reconciliations | ||||||||||||
For the Nine Months Ended |
||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||
Gross Profit | 2017 | 2016 | ||||||||||
Gross profit, GAAP | $ | 6,952 | $ | 6,876 | ||||||||
Global Growth and Efficiency Program | 51 | 31 | ||||||||||
Gross profit, non-GAAP | $ | 7,003 | $ | 6,907 | ||||||||
|
||||||||||||
Gross Profit Margin | 2017 | 2016 | Change | |||||||||
Gross profit margin, GAAP | 60.1 | % | 59.9 | % | 20 | |||||||
Global Growth and Efficiency Program | 0.5 | % | 0.3 | % | ||||||||
Gross profit margin, non-GAAP | 60.6 | % | 60.2 | % | 40 | |||||||
Selling, General and Administrative Expenses | 2017 | 2016 | ||||||||||
Selling, general and administrative expenses, GAAP | $ | 4,124 | $ | 3,996 | ||||||||
Global Growth and Efficiency Program | (60 | ) | (49 | ) | ||||||||
Selling, general and administrative expenses, non-GAAP | $ | 4,064 | $ | 3,947 | ||||||||
|
||||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2017 | 2016 | Change | |||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.7 | % | 34.8 | % | 90 | |||||||
Global Growth and Efficiency Program | (0.6 | )% | (0.4 | )% | ||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.1 | % | 34.4 | % | 70 | |||||||
Other (Income) Expense, Net | 2017 | 2016 | ||||||||||
Other (income) expense, net, GAAP | $ | 163 | $ | (2 | ) | |||||||
Global Growth and Efficiency Program | (135 | ) | (76 | ) | ||||||||
Gain on sale of land in |
— | 97 | ||||||||||
Charge for a previously disclosed litigation matter | — | (6 | ) | |||||||||
Other (income) expense, net, non-GAAP | $ | 28 | $ | 13 | ||||||||
Operating Profit | 2017 | 2016 | % Change | |||||||||
Operating profit, GAAP | $ | 2,665 | $ | 2,882 | (8 | )% | ||||||
Global Growth and Efficiency Program | 246 | 156 | ||||||||||
Gain on sale of land in |
— | (97 | ) | |||||||||
Charge for a previously disclosed litigation matter | — | 6 | ||||||||||
Operating profit, non-GAAP | $ | 2,911 | $ | 2,947 | (1 | )% | ||||||
|
||||||||||||
Operating Profit Margin | 2017 | 2016 | Change | |||||||||
Operating profit margin, GAAP | 23.0 | % | 25.1 | % | (210 | ) | ||||||
Global Growth and Efficiency Program | 2.2 | % | 1.4 | % | ||||||||
Gain on sale of land in |
— | % | (0.8 | )% | ||||||||
Charge for a previously disclosed litigation matter | — | % | — | % | ||||||||
Operating profit margin, non-GAAP | 25.2 | % | 25.7 | % | (50 | ) | ||||||
Table 9 | ||||||||||||||||||||||||||||
Continued | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Non-GAAP Reconciliations | ||||||||||||||||||||||||||||
For the Nine Months Ended |
||||||||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||||||||||||||||
2017 | ||||||||||||||||||||||||||||
Income Before
Income Taxes |
Provision For Income Taxes(1) |
Net Income
Including Noncontrolling Interests |
Net Income
Attributable To Colgate- Palmolive Company |
Effective Income
Tax Rate(2) |
Diluted Earnings
Per Share(3) |
|||||||||||||||||||||||
As Reported GAAP | $ | 2,591 | $ | 770 | $ | 1,821 | $ | 1,701 | 29.7 | % | $ | 1.91 | ||||||||||||||||
Global Growth and Efficiency Program | 246 | 61 | 185 | 185 | (0.4 | )% | 0.21 | |||||||||||||||||||||
Non-GAAP | $ | 2,837 | $ | 831 | $ | 2,006 | $ | 1,886 | 29.3 | % | $ | 2.12 | ||||||||||||||||
2016 | ||||||||||||||||||||||||||||
Income Before
Income Taxes |
Provision
Income |
Net Income
Including Noncontrolling Interests |
Less: Income
Attributable To Noncontrolling Interests |
Net Income
Attributable To Colgate- Palmolive Company |
Effective Income
Tax Rate(2) |
Diluted Earnings
Per Share(3) |
||||||||||||||||||||||
As Reported GAAP | $ | 2,804 | $ | 846 | $ | 1,958 | $ | 123 | $ | 1,835 | 30.2 | % | $ | 2.04 | ||||||||||||||
Global Growth and Efficiency Program | 156 | 41 | 115 | 1 | 114 | (0.2 | )% | 0.13 | ||||||||||||||||||||
Gain on sale of land in |
(97 | ) | (34 | ) | (63 | ) | — | (63 | ) | (0.2 | )% | (0.07 | ) | |||||||||||||||
Benefits from previously disclosed tax matters | — | 35 | (35 | ) | — | (35 | ) | 1.2 | % | (0.04 | ) | |||||||||||||||||
Charge for a previously disclosed litigation matter | 6 | 2 | 4 | — | 4 | — | % | — | ||||||||||||||||||||
Non-GAAP | $ | 2,869 | $ | 890 | $ | 1,979 | $ | 124 | $ | 1,855 | 31.0 | % | $ | 2.06 |
Notes: | ||
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
||
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
||
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between GAAP and non-GAAP as a result of rounding. |
||
View source version on businesswire.com: http://www.businesswire.com/news/home/20171027005119/en/
or
Source:
News Provided by Acquire Media